论文部分内容阅读
[目的]观察喜炎平联合双歧杆菌治疗小儿病毒腹泻的临床疗效。[方法]2010年2月~2011年2月,112例病毒腹泻患儿随机分为两组,对照组56例采用病毒唑治疗,观察组56例采用喜炎平联合双歧杆菌治疗,比较观察两组的临床疗效、止泻、退热时间和住院时间。[结果]观察组的总有效率明显高于对照组(P﹤0.05)。观察组的平均止泻时间、平均退热时间和住院时间均明显短于对照组(P﹤0.05)。[结论]喜炎平联合双歧杆菌治疗小儿病毒腹泻进行治疗,能够明显提高疗效,改善患儿临床症状,值得临床推广应用。
[Objective] To observe the clinical efficacy of Xiyanping combined with Bifidobacterium in treating children with viral diarrhea. [Methods] From February 2010 to February 2011, 112 children with viral diarrhea were randomly divided into two groups. 56 cases in the control group were treated with Ribavirin, and 56 cases in the observation group were treated with Xiyanping combined with Bifidobacterium. The two groups of clinical efficacy, antidiarrheal, antipyretic time and hospital stay. [Results] The total effective rate in observation group was significantly higher than that in control group (P <0.05). The average anti-diarrhea time, average antipyretic time and hospital stay in the observation group were significantly shorter than those in the control group (P <0.05). [Conclusion] Xiyanping combined with Bifidobacterium in the treatment of infantile virus diarrhea can significantly improve the curative effect and improve the clinical symptoms of children, which is worthy of clinical application.